IL-35 subunit EBI3 alleviates bleomycin-induced pulmonary fibrosis via suppressing DNA enrichment of STAT3

Respiratory Research

Table 1 Patient information

Sample name	Disease	Gender	Age	FEVI%pred	FVC%pred	Drug for antifibrotics
PBMC#1	Pulmonary fibrosis	Female	47	55.8	84.2	No
PBMC#2	Pulmonary fibrosis	Male	45	77.2	83	Esbriet
PBMC#3	Pulmonary fibrosis	Male	51	63.9	80.6	No
PBMC#4	Pulmonary fibrosis	Female	30	81.9	75.6	Esbriet
PBMC#5	Pulmonary fibrosis	Male	42	76.3	80.9	No
PBMC#6	Pulmonary fibrosis	Female	33	81.3	71.2	No
PBMC#7	Pulmonary fibrosis	Female	38	77.8	85.7	No
PBMC#8	Pulmonary fibrosis	Female	54	57.1	76.5	No
PBMC#9	Pulmonary fibrosis	Male	55	67.6	73.6	No
PBMC#10	Pulmonary fibrosis	Male	38	88	72.2	Esbriet
PBMC#11	Pulmonary fibrosis	Male	20	69.5	71.8	No
PBMC#12	Pulmonary fibrosis	Female	49	62.2	75.4	No
PBMC#13	Pulmonary fibrosis	Female	29	62.2	70.7	No
PBMC#14	Pulmonary fibrosis	Male	58	79.9	85.6	No
PBMC#15	Pulmonary fibrosis	Female	42	74	81.6	No
PBMC#16	Pulmonary fibrosis	Male	48	76.7	80.6	No
PBMC#17	Pulmonary fibrosis	Male	35	60.1	80.2	No
PBMC#18	Healthy control	Female	51	95.4	96.1	No
PBMC#19	Healthy control	Male	29	94.6	95.4	No
PBMC#20	Healthy control	Female	34	96.4	96.9	No
PBMC#21	Healthy control	Female	51	96.1	96.6	No
PBMC#22	Healthy control	Male	36	88.9	90.2	No
PBMC#23	Healthy control	Male	41	97.2	97.7	No
PBMC#24	Healthy control	Male	51	95.4	96.1	No
PBMC#25	Healthy control	Male	55	98.3	98.7	No
PBMC#26	Healthy control	Male	32	87.6	89	No
PBMC#27	Healthy control	Female	42	89.6	90.9	No
PBMC#28	Healthy control	Female	36	92.9	93.8	No
PBMC#29	Healthy control	Female	32	89.6	90.9	No
PBMC#30	Healthy control	Female	48	87.3	88.7	No
PBMC#31	Healthy control	Male	58	93.2	94.1	No
PBMC#32	Healthy control	Male	55	94	94.8	No
PBMC#33	Healthy control	Female	53	86.1	87.7	No
PBMC#34	Healthy control	Female	52	85	86.7	No
PBMC#35	Healthy control	Male	38	90.2	91.5	No

ISSN: 1465-993X